| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-13 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-13 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.26 | 2e-13 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-13 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-13 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-12 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-12 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-11 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-11 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-10 |